Table 3.
Data of Four Infants Follow-up by Optos 200Tx
NO. | Sex | GA | Birth Weight | CGA | Weight | ROP (OD) | ROP (OS) | Therapy |
1 | Female | 29 | 1,230 | 36 | 3,000 | Stage 3 in Zone I, plus (+) | Stage 3 in zone I | Anti-VEGF therapy (ou) at 36 w |
37 | 3,130 | Vessels grew to Zone II | Vessels grew to Zone II | |||||
2 | Female | 33 | 1,850 | 37 | 2,400 | Stage 2 in Zone II | Stage 2 in Zone II | Anti-VEGF therapy (ou) at 35 w |
38 | 2,770 | Stage 2 in Zone II | Stage 2 in Zone II | |||||
41 | 3,980 | Stage 1 in Zone II | Stage 2 in Zone II | |||||
3 | Male | 27 | 995 | 42 | 3,825 | Stage 3 in Zone II | Stage 2 in Zone II | Laser photocoagulation (ou) at 42 w |
46 | 5,740 | After laser photocoagulation | After laser photocoagulation | |||||
4 | Female | 31 | 1,550 | 38 | 2,980 | Stage 3 in Zone II | Stage 3 in Zone II | Anti-VEGF therapy (ou) at 34 w |
39 | 3,500 | Stage 3 in Zone II | Stage 3 in Zone II |